Plain-English translation of NCT06430749 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Prostate Cancer research guide →This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing a new minimally invasive procedure called targeted microwave tissue coagulation for men with early-stage prostate cancer. The procedure uses microwave heat to destroy cancer lesions in the prostate while preserving as much healthy prostate tissue as possible. Researchers will track how well the treatment works and monitor your quality of life for up to six months after the procedure.
Standard prostate cancer treatments can sometimes affect urinary and sexual function because they remove or damage large portions of the prostate. This trial is exploring whether this focused microwave treatment can destroy cancer while preserving more of your prostate's normal function.
You will receive the microwave tissue coagulation procedure under general anesthesia, performed using ultrasound guidance to target only the cancer lesion. After the procedure, you will have follow-up visits and imaging scans to check how well the treatment worked and how you are recovering. You will also complete surveys about your quality of life, urinary function, and sexual function for up to six months after the procedure.
AI-generated summary from trial data · Jun 26, 2026 · Not medical advice
Japan